TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 20.314 million compared to TWD 29.618 million a year ago. Operating loss was TWD 277.133 million compared to TWD 258.397 million a year ago. Net loss was TWD 295.685 million compared to TWD 343.210 million a year ago. Basic loss per share was TWD 0.41 compared to TWD 0.48 a year ago.